epithalon protocol AEDG Research Peptide – Peptagon Epithalon | Next Gen Peptides

When available, third-party lab reports are published on product pages so laboratories can review them before ordering.

Sleep Study Data: Results from polysomnography (PSG) or actigraphy to assess sleep efficiency, latency, wake after sleep onset (WASO), and apnea-hypopnea index (AHI) if relevant

In research observations, occasional non-specific findings such as mild gastrointestinal disturbance have been noted with oral administration of peptide compounds in general

Petersen, R

Common Protocol: Tesamorelin: 1 mg daily, subcutaneous BPC-157: 250500 mcg daily TB500: 25 mg per week Cycle: 812 weeks, often used post-injury or during high-recovery phases Key Notes: Peptides can be cycled to avoid desensitization and maintain effectiveness

Key highlights Lyophilized 5 mg vial Supplied as a sterile lyophilized powder in a sealed glass vial for stable, long-term storage